Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
The researchers at the University of Pennsylvania had developed this immunotherapy technique and demonstrated its utility in treating patients, ...
On March 5, a novel way to treat lung cancer won approval from the Food and Drug Administration (FDA). The latest drug, Opdivo, has showed ...
Sitkovsky said that supplemental oxygen found that supplemental oxygen can stop the hypoxia. It in return can improve cancer immunotherapy.
BACKGROUND: Immunotherapy with granulocyte-macrophage ... trials with maintenance immunotherapy in patients with advanced prostate cancer.
“The study revealed the risk of pancreatic cancer was greatest after the diagnosis of diabetes but remained elevated long after the diagnosis,” says ...
Websites that market personalized cancer care services often ... A late-stage pancreatic cancer patient's life "was extended five years by (our ...
As cancer cells transition from primary to metastatic they increasingly evolve mechanisms to hide from the immune system that normally detects and ...
Tests have shown it can work against squamous non-small cell lung cancer ... These are lab engineered immune system proteins that help the body ...
The therapies, which trigger the body's immune system to fight cancer cells, are expected to be worth $30 billion or more in the next decade and have ...
How AbbVie beat out behemoth J&J to buy Pharmacyclics - Crain's Chicago Business
AbbVie purchase gives it cancer therapy foothold - Taipei Times
ORLANDO, Florida — In patients with relapsed or refractory urothelial carcinoma, the antitumor activity of paclitaxel chemotherapy plus the targeted ...
PURPOSE: To estimate the bladder cancer mortality in persons with spinal cord injury (SCI), as compared to the general population. MATERIALS AND ...
Intravesical instillation of Bacillus Calmette-Guérin (BCG) is a mainstay of adjunctive therapy for superficial bladder cancer. Disseminated BCG ...
Science Daily Cancer News
A highly aggressive form of leukemia in infants has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene, researchers have found. The findings suggest that targeting the alteration is likely the key to improved survival.
Oncologists praise gene expression profiling tests as a decision-making tool for women with early-stage breast cancer but also have significant reservations.
Tambahkan Komentar